·
Specific
genetic conditions are believed
to account for <5% of all pediatric
malignancies.
·
The clinical features of the childhood leukemias are similar, because all involve severe disruption of bone
marrow function. There is marked variability in response to therapy and in the
prognosis.
·
About
20-30% of neonates with Down
syndrome who develop a transient leukemia or myeloproliferative syndrome
will develop typical leukemia within the first few years of life.
·
More than two
thirds of cases of infant leukemia
demonstrate rearrangements of the MLL gene, classically a translocation
involving the q23 band of chromosome 11, and it is this subset of patients that
largely accounts for the very high relapse rate.
·
Children with
neuroblastoma with early-stage
disease without amplified MYCN or chromosome 1p deletion can usually be
cured with surgery alone. Children <1 yr of age have a 95% 3-yr survival
rate, compared with 25-50% for children 1-5 yr of age.
·
Opsomyoclonus ("dancing eyes and dancing feet") is a paraneoplastic syndrome of autoimmune origin
that is associated with neuroblastoma.
·
The patients at highest risk of Tumor Lysis Syndrome those with the most
rapidly dividing tumors. The highest risk is with Burkitt's
lymphoma/leukemia, followed by T-lineage acute lymphoblastic leukemia and
T-cell lymphoblastic lymphoma.
·
Children who require repeated blood draws or intravenous
medications often have a semipermanent central venous catheter placed.
A Broviac catheter is tunneled through the
subcutaneous tissues of the chest and emerges as a thin plastic tube, usually
at the level of the second or third rib.
A Port-A-Cath contains a subcutaneous reservoir
and is implanted under the skin of the chest. It is not visible, but it must be
accessed by inserting a small needle through the skin and into the reservoir.
·
Diencephalic
syndrome is the constellation of symptoms that result from the
presence of a hypothalamic tumor: euphoria, emaciation, and emesis.
·
Parinaud's
syndrome is the result of increased intracranial pressure at the
dorsal midbrain, causing downgaze, papillary dilation, and nystagmus.
·
Bilateral Wilms' tumor is known as a stage
V tumor. Each tumor is staged independently; prognosis with bilateral
disease is not necessarily poor.
·
Conditioning is the preparative process,
performed by either chemotherapy or
chemoradiotherapy, that is designed to destroy residual malignant
cells, to provide immunosuppression to minimize the chance of rejection, and to
create space in the marrow itself for the transplantation (bone-marrow
ablation).
No comments:
Post a Comment